NCT01716598View on ClinicalTrials.gov

Evaluation of the IPS System for TLD Therapy in Patients With COPD

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

April 30, 2016

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DEVICE

IPS System

TLD Therapy will be achieved bronchoscopically.

Trial Locations (4)

1140

Otto-Wagner Hospital and Medical Center, Sanatoriumstrasse 2

Unknown

Centre Hospitalier et Universitaire de Grenoble, Grenoble

Centre Hospitalier University de Reims, Reims

Nouvel Hopital Civil, Strasbourg

Sponsors

Lead Sponsor

Nuvaira, Inc.
All Listed Sponsors
lead

Nuvaira, Inc.

INDUSTRY

NCT01716598 - Evaluation of the IPS System for TLD Therapy in Patients With COPD | Biotech Hunter | Biotech Hunter